NEWS
Institutional Subscription: Comprehensive Analyses to Enhance Your Global and Local Impact
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 221 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
Login
Register & Pricing
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Elizabeth Tullis
University of Toronto - Toronto / Canada
Others
AD Scientific Index ID: 4930366
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Elizabeth Tullis's MOST POPULAR ARTICLES
1-)
A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation BW Ramsey, J Davies, NG McElvaney, E Tullis, SC Bell, P Dřevínek, ... New England Journal of Medicine 365 (18), 1663-1672, 2011 21672011
2-)
Elexacaftor–tezacaftor–ivacaftor for cystic fibrosis with a single Phe508del allele PG Middleton, MA Mall, P Dřevínek, LC Lands, EF McKone, D Polineni, ... New England Journal of Medicine 381 (19), 1809-1819, 2019 10132019
3-)
Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind …HGM Heijerman, EF McKone, DG Downey, E Van Braeckel, SM Rowe, ...The Lancet 394 (10212), 1940-1948, 20198442019
4-)
The future of cystic fibrosis care: a global perspectiveSC Bell, MA Mall, H Gutierrez, M Macek, S Madge, JC Davies, PR Burgel, ...The Lancet Respiratory Medicine 8 (1), 65-124, 20209472020
5-)
Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practiceC Castellani, H Cuppens, M Macek Jr, JJ Cassiman, E Kerem, P Durie, ...Journal of cystic fibrosis 7 (3), 179-196, 20088942008
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept